REG - Primary Health Props - Director Declaration

Primary Health PropertiesAnnouncement

03/05/2022 17:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220503:nRSC1856Ka&default-theme=true

RNS Number : 1856K  Primary Health Properties PLC  03 May 2022

 

Primary Health Properties PLC

(the "Company" or "PHP")

 

Director appointment

 

Primary Health Properties PLC, a leading investor in modern primary healthcare
facilities, announces, in accordance with Listing Rule 9.6.14(2), that Mr
Richard Howell, Chief Financial Officer of the Company, has been appointed as
a Non-executive Director of Life Science REIT plc (AIM: LABS), an externally
managed real estate investment trust recently admitted to trading on the AIM
market of the London Stock Exchange and focused on investing in a diversified
portfolio of UK properties that are leased or intended to be leased to tenants
operating in the life science sector.

 

ENDS

 

Further details:

 

 Harry Hyman                                                    Steven Owen

 Chief Executive Officer                                        Chairman

 Tel: +44 (0) 0797 3344768                                      Tel: +44 (0) 20 7451 7050

 David Rydell / Steph Whitmore / Tilly Abraham

(Buchanan Communications)

 Tel: +44 (0) 20 7466 5066

 

 

 

More information on Primary Health Properties PLC can be found
on www.phpgroup.co.uk (http://www.phpgroup.co.uk/)

 

Legal Entity Identifier: 213800Y5CJHXOATK7X11

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNAJMFTMTJMBJT